Industry Connect with CSL
UQ researchers joined online information sessions to hear
Dr Marthe D’Ombrain of CSL launch their 2022 Research Acceleration Initiative.
CSL’s Research Acceleration Initiative aims to fast-track discovery of innovative biotherapies that fall within CSL’s therapeutic focus areas and modalities, through partnerships between CSL and UQ, and other Australian and global research organisations.
Applications have now closed.
Successful applicants will receive up to $250,000 per year for up to 2 years (max $500,000 funding) to accelerate translation of their research.
The Initiative will focus on target validation and drug discovery projects in CSL’s therapeutic areas and modalities of interest, as stated below. Download CSL flyer for more detailed information on the therapeutic focus areas.
Therapeutic areas
Immunology
Hematology
Respiratory
Cardiovascular and Metabolic
Transplant
Modalities
Antibodies
Recombinant proteins
Cell & gene therapies
Small molecules NOT of interest
Next steps
Join online webinar information sessions
Download application form and discuss with UniQuest
Internal deadline: submit your application to csl@uniquest.com.au by 18 Feb for review and feedback
Deadline to CSL: UniQuest will coordinate submissions to CSL by 28 Feb.
Online information session details
Time
1:00pm - 2:00pm (Brisbane time)
11:00am - 12:00pm (Brisbane time)
Date
Monday, 7 February 2022
Wednesday, 9 February 2022
Online session links
To register for webinar sessions, please email
csl@uniquest.com.au
For more information in your research area, contact:
Dr Craig Belcher
c.belcher@uniquest.com.au
Dr Tamsin Terry
t.terry@uniquest.com.au
Dr David Markwell
d.markwell@uniquest.com.au
Dr George Adamson
g.adamson@uniquest.com.au
Julian Vultaggio
j.vultaggio@uniquest.com.au
